Skip to main content
Weiter zur Homepage der Europäischen Kommission (öffnet in neuem Fenster)
Deutsch de
CORDIS - Forschungsergebnisse der EU
CORDIS

Commercialising a smart cardiac implant platform for the treatment of chronic cardiovascular disease

Ziel

Every year chronic cardiac disease causes 3.9 million deaths in Europe, that’s a death every 8 seconds. Overall chronic cardiac disease is estimated to cost the EU €210 billion/yr, in direct healthcare costs. All chronic cardiac disease patients are at high risk of stroke, atrial fibrillation, &/or heart failure
The AuriGen platform is single minded in its focus on the leading causes of death in the developed world – Cardiovascular Diseases. Allowing more complex patients to be treated more effectively, and at a lower cost per patient.
AuriGen’s platform of 4 devices is built around our custom cardiac implant, to which we can add synergistic modules such as cardiac monitoring, ablation or both modules. Creating devices which are much more than the sum of their parts, this our key USP. Allowing AuriGen to efficiently & effectively manage the most expensive & sub-optimally treated patients, in a single, safe, fast minimally invasive procedure.

Wissenschaftliches Gebiet (EuroSciVoc)

Schlüsselbegriffe

Programm/Programme

Thema/Themen

Finanzierungsplan

HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended Finance

Alle im Rahmen dieses Finanzierungsinstruments finanzierten Projekte anzeigen

Aufforderung zur Vorschlagseinreichung

(öffnet in neuem Fenster) HORIZON-EIC-2022-ACCELERATOR-01

Alle im Rahmen dieser Aufforderung zur Einreichung von Vorschlägen finanzierten Projekte anzeigen

Koordinator

AURIGEN MEDICAL LIMITED
Netto-EU-Beitrag
€ 2 499 999,00
Adresse
18 CHURCHWELL SQUARE
DUBLIN 13 Dublin
Irland
KMU
Ja
Region
Ireland Eastern and Midland Dublin
Aktivitätstyp
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Gesamtkosten
€ 3 999 999,75